Rare diseases
Investigational molecules
Locations
Fogdevreten 2a, 171 65 Solna, Sweden
Clinical research is centered on blood cancers, with attention to advanced and relapsed or refractory disease. The therapeutic scope includes acute myeloid leukemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, multiple myeloma, and high-risk myelodysplastic syndromes.
Research activity also extends to combination treatment approaches in relapsed/refractory hematologic cancer, reflecting interest in difficult-to-treat malignant disorders of the blood and lymphatic system.
Thomas Helledays Stiftelse Foer Medicinsk Forskning runs clinical trials in conditions such as Haematological malignancy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
